Health officials have turned their attention to the rapid propagation of a fungus that has been identified as an imperative antimicrobial resistance threat within healthcare facilities. This fungus, known as Candida auris or C. auris, possesses characteristics that make it a significant concern, from its resilience against multiple antifungal drugs to its capacity to cause…
The incidence of Candida auris, a deadly fungal infection, is escalating alarmingly in numerous hospitals across the United States, causing an increasing number of infections and fatalities. According to data from the American Journal of Infection Control, this invasive fungal infection has been identified in half the states, including New York, with an exponential increase…
The United States continues to grapple with a lethal enemy propagating within hospital walls: Candida auris, a drug-resistant fungus that has been thriving unchecked. The story of this dangerous pathogen adds a chilling chapter to the nation's healthcare narrative, with its presence now recorded in 29 states. The threat level of this fungus is reflected…
Recent studies have dwelled on the escalating trend of the fungal infection, Candida auris, which has been on a disturbing rise. Notably, this increase is not contained to only single-source cases, but also, manifold sources have been spawning the infection. C. auris, ever since its first reported US case in 2016, has been recognized as…
The Centers for Disease Control and Prevention (CDC) has classified Candida auris, a potent yeast species, as an urgent antimicrobial resistance threat infiltrating US hospitals. Initially detected in Japan in 2009 and reported in the US in 2016, an alarming resurgence of this drug-resistant fungal infection is presently uncoiling, borne from versatile sources. This escalation…
Healthcare facilities across the United States are encountering an escalating challenge— the rapidly proliferating drug-resistant fungus, Candida auris. This yeast infection is causing widespread concern among health officials due to its growing prevalence, high mortality rate, and resistance to several antifungal medications. Since its initial detection on U.S. soil back in 2016, reports of Candida…
In an alarming development in the nation’s healthcare domain, a menacing fungus classified as Candida auris is steadily making inroads into U.S. hospitals, rapidly proving its potential as a potent, often deadly threat to public health. Designated as an 'urgent threat' by the U.S. Centers for Disease Control and Prevention (CDC), this fungus first gained…
The most recent revelations from an international phase 3 clinical trial showcase that those who commenced the antiviral drug ensitrelvir within 72 hours after a family member tested positive for COVID-19 had substantially decreased likelihood of infection. Shionogi, a Japanese pharmaceutical conglomerate, created ensitrelvir, which is currently permitted in Japan for handling mild to moderate…
An outbreak of multidrug-resistant Candida auris in a Burn Intensive Care Unit (BICU) in Illinois has brought the continuing challenges of infection regulation to light in high-aspect clinical environments. Despite intensive containment endeavours, Candida auris, a novel fungal pathogen with extensive drug resistance and environmental persistence, continued to propagate, illustrating a dire need for advanced…
Jackson Health System, a renowned non-profit academic medical organization in Miami, Florida, has recently reported a dramatic surge in the number of Candida auris (C. auris) infections over a five-year period, spanning from 2019 to 2023. Over these years, a steady annual increase of the menacing fungal infection was tangible with a drastic jump from…